GT Molecular Launches Highly Sensitive PCR Tests for the SARS-CoV-2 Delta Variant and Influenza A/B
FORT COLLINS, Colo., July 13, 2021 /PRNewswire/ -- GT Molecular, an industry leader in wastewater testing and multiplex, ultrasensitive PCR assays for cancer and pathogen epidemiology, has started shipping its sensitive PCR tests to monitor the coronavirus Delta variant (B.1.617.2). The variant was first identified in India in December of 2020 and has been designated a variant of concern by the WHO due to extremely high transmissibility. Since its initial detection in the US in March of 2021, the Delta variant has spread rapidly and is now estimated to comprise the majority of all COVID 19 cases nationwide. In addition to SARS-CoV-2 variants, GT molecular now offers testing and PCR kits for the detection of Influenza A and B, empowering researchers and policymakers to accurately monitor community pathogen levels and make sound data driven decisions.
The new offerings include Targeted Wastewater Testing Service and PCR kits with quantitative controls for:
Additional RT-qPCR kits are available to screen for California (Epsilon, B.1.427/B.1.429), UK (Alpha, B.1.1.7), Brazil/Japan (Gamma, P.2) and South Africa (Beta, B.1.351) variants.
These new offerings add to GT Molecular's growing molecular assay catalog that includes SARS-CoV-2 multi-variant tests, cancer panels, multiplexed pathogen panels for clinical labs and quantitative standards.
About GT Molecular
View original content to download multimedia:https://www.prnewswire.com/news-releases/gt-molecular-launches-highly-sensitive-pcr-tests-for-the-sars-cov-2-delta-variant-and-influenza-ab-301332788.html
SOURCE GT Molecular